News:

This week IPhone 15 Pro winner is karn
You can be too a winner! Become the top poster of the week and win valuable prizes.  More details are You are not allowed to view links. Register or Login 

Main Menu

Biogen's new MS drug tops expectations; ups 2013 forecast

Started by riky, October 29, 2013, 08:00:17 AM

Previous topic - Next topic

0 Members and 1 Guest are viewing this topic.

riky

Biogen's new MS drug tops expectations; ups 2013 forecast

<p><a href="http://news.yahoo.com/biogens-ms-drug-tops-expectations-earnings-rise-113522437--finance.html"><img src="http://l1.yimg.com/bt/api/res/1.2/kjC.J_tkdL3IVLcPjg2pNg--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9NzU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-10-28T113522Z_1_CBRE99R0W8600_RTROPTP_2_USA.JPG" width="130" height="86" alt="The company's name is displayed on a billboard near the headquarters of Biogen Idec Inc. in Cambridge" align="left" title="The company's name is displayed on a billboard near the headquarters of Biogen Idec Inc. in Cambridge" border="0" /></a>By Bill Berkrot (Reuters) - Biogen Idec Inc on Monday reported $286 million in third-quarter sales of its high-profile new multiple sclerosis drug Tecfidera, providing fresh evidence that the medicine is off to an impressive launch and exceeding all expectations. The company also reported higher-than-expected third-quarter earnings and raised its full-year profit and revenue forecasts, and its shares rose nearly 4 percent before paring gains. ...</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login
You are not allowed to view links. Register or Login